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ttps://doi.org/10.1016/j.ajpath.2020.05.010We studied the role of galectin-3 (Gal-3) in the expression of alternative activation markers (M2) on
macrophage, cytokines, and fibrosis through the temporal evolution of healing, ventricular remodeling,
and function after myocardial infarction (MI). C57BL/6J and Gal-3 knockout mice (Lgals3-/-) were
subjected to permanent coronary ligation or sham. We studied i) mortality, ii) macrophage infiltration
and expression of markers of alternative activation, iii) cytokine, iv) matrix metalloproteinase-2 ac-
tivity, v) fibrosis, and vi) cardiac function and remodeling. At 1 week post-MI, lack of Gal-3 markedly
attenuated F4/80þ macrophage infiltration and significantly increased the expression of Mrc1 and
Chil1, markers of M2 macrophages at the MI zone. Levels of IL-10, IL-6, and matrix metalloproteinase-2
were significantly increased, whereas tumor necrosis factor-a, transforming growth factor-b, and
fibrosis were remarkably attenuated at the infarct zone. In Gal-3 knockout mice, scar thinning ratio,
expansion, and cardiac remodeling and function were severely affected from the onset of MI. At 4 weeks
post-MI, the natural evolution of fibrosis in Gal-3 knockout mice was also affected. Our results suggest
that Gal-3 is essential for wound healing because it regulates the dynamics of macrophage infiltration,
proinflammatory and anti-inflammatory cytokine expression, and fibrosis along the temporal evolution
of MI in mice. The deficit of Gal-3 affected the dynamics of wound healing, thus aggravating the
evolution of remodeling and function. (Am J Pathol 2020, 190: 1789e1800; https://doi.org/10.1016/
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Disclosures: None declared.Myocardial infarction (MI) leads to a sequence of structural
and functional changes that promote the healing of the infarct
zone, ventricular remodeling (VR), and myocardial decom-
pensation.1 The temporal evolution of wound healing is
associated with the activation of a well-orchestrated and
balanced inflammatory response that leads to the formation of
a fibrous scar,2 which should provide a satisfactory tension
force to prevent infarct expansion3 and adverse remodeling.stigative Pathology. Published by Elsevier Inc. All rights reserved.
Cassaglia et alNevertheless, throughout the temporal evolution of wound
healing, the progression of MI to heart failure is also linked to
a multiplicity of interrelated factors associated with adverse
remodeling.4,5 Although the mechanisms responsible for the
evolution of post-MI VR are multiple, diverse, and complex,
the persistent increased activation of the inflammatory
response triggered during the repair of the infarct zone
notably contributes to the adverse evolution of left ventricular
(LV) structural changes and failure.6 Recent studies have
found that monocyte and macrophage subpopulations
recruited at the infarct zone exhibit a biphasic functional
heterogeneity, mainly orchestrated by the infiltration of M1
and M2 macrophages.7e9 Thus, monocytes and macrophages
promote a well-organized clearance of necrotic cells and
facilitate the repairing process by collagen synthesis.10e13
Largely, macrophages may also determine the evolution of
cardiac remodeling because exaggerated inflammation may
also affect the healing as seen by the increase in mortality of
hospitalized patients with MI.4,14 Therefore, targeting the
healing to improve MI consequences has proven to be
ambiguous15 because insufficient or disproportionate
inflammation at early stages of MI or limited or exaggerated
fibrosis at later stages will depend on temporal and spatial
factors.
Macrophages and fibroblasts that infiltrate the infarct
zone are the major sources of galectin-3 (Gal-3). Gal-3 is a
b-galactosidaseebinding lectin widely expressed in the
immune system and markedly involved in cardiovascular
pathophysiology as a proinflammatory and profibrotic
molecule.16,17 During the past few years, this lectin merged
as a strong prognostic factor in patients with coronary artery
disease and heart failure.18 In rodents, the synthesis of Gal-3
highly increased during the first 2 weeks after MI, sug-
gesting it is a regulatory factor in the regulation of wound
healing.17,19 Despite some essential cellular and molecular
factors along the temporal evolution of wound healing and
their pathophysiologic significance on cardiac remodeling,
the role of Gal-3 as a key factor in the temporal evolution of
macrophage infiltration, tissue repair, remodeling, and
function is still unknown. We hypothesized that Gal-3
regulates macrophage infiltration, the expression of
markers of its alternative activation, cytokine expression,
and fibrosis along the temporal evolution of wound healing
and thus contributes to the evolution of VR and cardiac
dysfunction in mice.
Materials and Methods
Mice and Experimental Models of MI
Male C57BL/6J and Gal-3 knockout (KO) (Lgals3-/-) mice
(8 to 10 weeks old) were used. C57BL/6J mice were pur-
chased from the Department of Bioresources of the Faculty
of Veterinary Sciences of the University of Buenos Aires,
Buenos Aires, Argentina, and used as controls. Gal-3 KO
mice were originally donated by Dr. Gabriel A. Rabinovich1790[Laboratorio de Inmunopatología, Instituto de Biología y
Medicina Experimental (IBYME-CONICET), Buenos
Aires, Argentina] and were bred on a C57BL/6J background
at the same bioresources facilities stated above. Mice were
anesthetized with intramuscular administration of ketamine
(65 mg/kg), xylazine (13 mg/kg), and acepromazine (1.5
mg/kg) and then intubated and given mechanical ventilatory
support using a Harvard ventilator (tidal volume, 250 mL per
stroke) at a respiratory frequency of 34 to 38 cycles per
minute, as described previously.20 Subsequently, lateral left
thoracotomy was performed followed by pericardiectomy
and ligature of a lateral branch of the left descending cor-
onary artery using an 8.0 silk thread. Finally, the chest was
closed by layers, and the animals were allowed to recover
from the anesthesia in a quiet environment. Animals in the
sham operation group underwent the same procedure
without ligature of the coronary artery. Finally, when ani-
mals recovered from anesthesia, they were housed in indi-
vidual cages until the end of the protocol. All the
experiments were approved by the Animal Care and
Research Committee of the University of Buenos Aires in
line with the NIH’s Guide for the Care and Use of Labo-
ratory Animals.21
Mice were randomized according to the evolution time
into the following groups: i) C57 sham, ii) Gal-3 KO sham,
iii) C57 MI, iv) Gal-3 KO MI for 1 week v) C57 sham, vi)
Gal-3 KO sham, vii) C57 MI, and viii) Gal-3 KO MI for 4
weeks.
Echocardiography
Echocardiography was performed at 1 and 4 weeks after
surgery in anesthetized animals (tribromoethanol; 1.15
mL/kg). LV dimensions (wall thickness, cavity size, and
areas in systole and diastole) and ventricular function
(ejection fraction, shortening fraction, and cardiac output)
were evaluated with a Doppler echocardiography system
equipped with a 12-MHz linear transducer (Acuson,
Mountain View, CA). Cardiac mass was also assessed as
previously described.16
Histologic Analysis
Randomized hearts from each group were subjected to
histologic examination (4 to 9 hearts per group). Hearts
were harvested and immersed in 10% formaldehyde for 72
hours. Later, they were cut from apex to base and embedded
in paraffin; 5-mm serial cuts were made, and sections were
stained with hematoxylin and eosin, Masson trichrome, and
Picrosirius red. In the sections, also stained with Picrosirius
red, interstitial collagen was measured in the septum and
scar using the image-analysis software (Image Pro-Plus
version 6.0, Media Cybernetics, Silver Spring, MD). The
percentage of collagen for each region was calculated by
adding the areas corresponding to collagen and dividing by
the addition of the areas corresponding to myocyte plus theajp.amjpathol.org - The American Journal of Pathology
Galectin-3 on Healing and Remodelingareas of collagen tissue as described elsewhere.16,22 Myo-
cyte cross-sectional areas were determined on digitalized
images of rhodamine-conjugated lectin-stained sections
(WGA RL-1022, Vector Laboratories, Burlingame, CA) of
paraffin-embedded samples. These digitalized images were
obtained using a fluorescence microscope (Olympus BX61,
Olympus, Tokyo, Japan) attached to a digital camera and
connected to a computer equipped with Image Pro-Plus
version 6.0. Outlines of myocyte were traced, and cell
areas were measured with Image Pro-Plus version 6.0.22
Quantitative Determination of Infarct Size and
Morphometry
Myocardial infarct size, wall thickness, and length of
endocardial and epicardial circumferences were measured
by planimetry from histologic images of the stained sec-
tions with Masson trichrome using the Image Pro-Plus
version 6.0 software. Infarct size was calculated as the
total length of the scar using the mean endocardial and
epicardial tracings as a percentage of the total LV
circumference.22 The scar thickness (mean of five equi-
distant measurements) and septum thickness (mean of
three equidistant measurements) were measured in a mid-
dle section of the heart. The scar thickness ratio was
calculated as the association of scar thickness and septum
thickness with the expansion index expressed as LV cavity
area/total LV area  septum thickness/scar thickness.23 In
a pilot experiment, a subset of C57 and Gal-3 KO mice
(n Z 5 per group) underwent permanent coronary artery
ligation at 24 hours, followed by immediate euthanasia;
hearts were perfused with Evan’s blue and then cut from
apex to base. The sections were incubated in 1% of tri-
phenyl tetrazolium chloride isotonic phosphate buffer (pH
7.4) (Sigma-Aldrich, St. Louis, MO) staining for mea-
surement of infarct size as described previously.24 Thus,
the infarct size was quantified at 24 hours after permanent
coronary artery ligation to ensure that initial injury was
comparable between groups.
Flow Cytometry
Hearts of 1-week infarcted mice (wild type or Gal-3 KO)
were processed to obtain single-cell suspensions by flow
cytometry. First, MI and LV tissues were harvested by
dissection and chopped into small pieces. A mechanical
disaggregation method, using pipette and steel mesh, was
performed, using phosphate-buffered saline (PBS) as buffer.
Cells were then recovered and washed with fresh PBS. After
refrigerated centrifugation at 500  g for 5 minutes, pellets
were resuspended in PBS and incubated with red blood cell
lysis buffer (155 mmol/L ammonium chloride, 12 mmol/L
sodium bicarbonate, 0.1 mmol/L EDTA, pH 7.3). After 20
minutes on ice, the reaction was stopped by the addition of
PBS. Cells were centrifuged at 500  g for 5 minutes and
then washed once again in PBS. Thus, 0.3 to 2  106 cellsThe American Journal of Pathology - ajp.amjpathol.orgwere placed in FACS tubes. Then, all samples were blocked
with 10% mouse serum for 30 minutes on ice. This was
followed by staining all samples for 30 minutes on ice with
anti-mouse F4/80 conjugated with phosphatidylethanol-
amine (eBioscience, San Diego, CA) at the appropriate
dilution (in PBS and 1% fetal bovine serum) in line with the
manufacturer’s guidelines. Cells were then washed in 1%
fetal bovine serum and PBS before acquisition and analysis.
Data were collected in a PARTEC PAS IIIcytometer (Sys-
mex Partec GmgH, Görlitz, Germany) and analyzed using
Flowing Software (Turku Bioimaging, Turku, Finland) and
CellQuest Pro software (BD Biosciences, Franklin Lakes,
NJ) to determine the percentage of infiltrated macrophages
at both MI and remote zone.
Zymography
Matrix metalloproteinase (MMP)-2 activity from the infarct
zone was measured by gelatinolitic zymography. Briefly,
cardiac tissue was homogenized in 50 mmol/L Tris buffer,
pH 7.4, containing 5 mmol/L calcium chloride, 1 mmol/L
zinc chloride, and 1% Triton X-100. Protein (120 mg) was
applied to nonreduced SDS-PAGE using 7.5% gel copoly-
merized with gelatin 0.1% (G-8150, Sigma-Aldrich). Gels
were run 3 hours in 25 mmol/L Tris, 192 mmol/L glycine,
0.1% SDS at 4C, pH 8.3, in a Mini Protean-3 (BioRad
Laboratories, Hercules, CA). After running, gels were rinsed
with 2.5% Triton X-100 for 30 minutes and then incubated
for 18 hours in 0.15 mol/L sodium chloride, 10 mmol/L
calcium chloride, Tris hydrochloride, pH 7.4, at 37C. After
staining with Coomassie blue R-250 (B-0149, Sigma-
Aldrich) and destaining with acetic acid, methanol, and
water (1:3:6); enzyme activity was detected as colorless
bands against the blue-stained background. MMP-2 (67
kDa, active form) and MMP-9 (84 kDa, active form) were
identified by molecular weight. Conditioned media from the
promyelocyte U-937 cell lines were used as a standard ac-
tivity. Coefficients of variation were 4.8% (intra-assay) and
8.6% (interassay). Band intensities were quantified using
ImageJ software (NIH, Bethesda, MD; http://imagej.nih.
gov/ij), and relative activity was expressed as a ratio to
the internal standard.
Quantitative Real-Time RT-PCR
Total RNA was extracted from heart tissue homogenates
by using a QuickZol reagent (Kalium Technologies, Bue-
nos Aires, Argentina). Total RNA was reverse transcribed
using Expand Reverse Transcriptase (Invitrogen Corp.,
Waltham, MA). Quantitative real-time PCR was performed
using a 5  HOT FIREPol EvaGreen qPCR Mix Plus
(ROX) (Solis BioDyne Corp., Tartu, Estonia) in a StepOne
System. Primer sequences were as follows: tumor necrosis
factor Tnf (TNF-a) forward: 50-ATGAGCACA
GAAAGCATGATC-30, reverse: 50-TACAGGCTTGT
CACTCGAATT-30; IL-6 (also known as Il6) forward:1791
Cassaglia et al50-TGATGCACTTGCAGAAAACAA-30, reverse: 50-GGT
CTTGGTCCTTAGCCACTC-30; Ym1 (also known as
Chil1), forward: 50-GGATGGCTACACTGGAGAAA-30,
reverse: 50-AGAAGGGTCACTCAGGATAA-30; mannose
receptor (CD206, also known as Mrc1) forward: 50-
CAAGGAAGGTTGGCATTTGT-30, reverse: 50-CCTTT
CAGTCCTTTGCAAGC-30; IL-10 (also known as Il10)
forward 50-CTCCCCTGTGAAAATAAGAGCA-30;
reverse 50-TCCAGCAGACTCAATACACACT-30; and
transforming growth factor (Tgfb1, also known as TGF-b):
forward 50-CACCGGAGAGCCCTGGATA-30; reverse 50-
TGTACAGCTGCCGCACACA-30. All samples were
analyzed in the same run for 18S expression for normali-
zation: forward: 50 AACACGGGAAACCTCACCC-30 and
reverse: 50-CCACCAACTAAGAACGGCCA-30. PCR pa-
rameters were 52C for 2 minutes, 95C for 15 minutes,
and 40 cycles of 95C for 30 seconds and 60C (for IL-6,
mannose receptor, IL-10, TNF-a, and 18S) or 63C (for
TGF-b) or 56C (for Ym1) for 1 minute. Quantification
was performed using the comparative threshold cycle
method because all the primer pairs (target gene and
reference gene) were amplified using comparable effi-
ciencies (relative quantity, 2DDCt). The replicates were
then averaged and fold induction was determined,
considering the value at time zero as 1.25C57 (1 week)
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Figure 1 A: Survival rates after myocardial infarction (MI) in C57 and galacti
with MI. Gal-3 KO mice who died had larger hearts. C: Representative images of Eva
MI and infarct size quantification at that time. D and E: Echocardiography in both s
KO MI mice; yP < 0.05 versus sham. Scale bars: 5 mm (B); 1 mm (C). LVDD, le
diameter.
1792Western Blotting
Tissues from the LV infarcted zone were homogenized in 20
mmol/L Tris buffer, pH 7.4, containing 150 mmol/L sodium
chloride, 1% Triton X-100, and 2% protease inhibitor cock-
tail (Sigma-Aldrich). Tissue homogenates were centrifuged
and protein concentrations were determined by the Lowry
method in the supernatant.26 Fifty micrograms of protein
from each sample were separated in 12% SDS-PAGE and
electroblotted onto polyvinylidenedifluoride membranes.
Blots were blocked with 5% skimmed milk for 1 hour and
incubated overnight at 4C with a polyclonal rabbit IgG
antibody against TGF-b (Santa Cruz Biotechnology Inc.,
Heidelberg, Germany) and against b-actin (Sigma-Aldrich).
After washing with Tris buffer saline and Tween 0.1%, blots
were incubated with peroxidase-conjugated secondary anti-
body (Boster Biological Technology, Pleasanton, CA) for
1.30 hours at room temperature. The specific signals were
visualized using the LAS 4100/GE transilluminator (General
Electric, Boston, MA). Bands were identified by the use of
prestained molecular weight standards (BioRad Labora-
tories). The relative intensity of the protein signal was
quantified by densitometric analysis using the Fluorchem
program (Alpha Innotech Corp., San Leandro, CA). Results
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C57 Sham (n = 5)
Gal-3 KO Sham (n = 4)
C57 MI (n = 13)


























































n-3 (Gal-3) knockout (KO) (Lgals3-/-) mice; B: Macroscopy images of hearts
n’s blue and tetrazolium chloride stained section of hearts at 24 hours after
trains of mice at 1 week (D) and 4 weeks (E). *P < 0.05 C57 MI versus Gal-3
ft ventricular end diastolic dimension; LVESD, left ventricular end systolic
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Table 1 Necropsy at 7 Days and 4 Weeks after MI
Variable
1 Week after MI 4 Weeks after MI
C57 sham Gal-3 KO sham C57 MI Gal-3 KO MI C57 sham Gal-3 KO sham C57 MI Gal-3 KO MI
BW, g 26  0.8 28  0.6 25  0.4 27  0.5 30  1.6 31  0.5 29  0.8 31  0.6
HW/BW, mg/g 5  0.1 5  0.2 6  0.2 6  0.2* 4  0.2 4  0.2 6  0.2yz 6  0.2*x
LW/BW, mg/g 9  0.4 8  0.5 9  0.4 15  1.2*{ 5  0.4 5  0.1 5  0.1 6  0.1
HW/TL, mg/g 7  0.4 7  0.4 8  0.4 9  0.4* 7  0.3 8  0.5 10  1.4 10  0.9
Data are expressed as means  SEM.
*P < 0.05 Gal-3 KO MI versus Gal-3 KO sham.
yP < 0.05 C57 MI versus C57 sham.
zP < 0.05 C57 MI versus 05 Gal-3 KO sham.
xP < 0.05 Gal-3 KO MI versus C57 sham.
{P < 0.05 Gal-3 KO MI versus C57 MI.
BW, body weight; Gal-3, galactin-3, also known as Lgals3; HW, heart weight; KO, knockout; LW, lung weight; MI, myocardial infarction; TL, tibia length.
Galectin-3 on Healing and RemodelingStatistical Analysis
Continuous variables are presented as means  SEM.
Parametric data were analyzed using the unpaired t-test to
compare the two groups with infarction and one-way anal-
ysis of variance, followed by Bonferroni post hoc test for
multiple-comparison test using Prism software version 6.0
(GraphPad Software, San Diego, CA). A survival analysis
was performed by the Kaplan-Meier method with log-rank
test. P < 0.05 was considered statistically significant.
Results
Post-MI Survival, Cardiac Remodeling, and Function
At 4 weeks after MI, the survival rate was significantly
reduced in Gal-3 KO mice compared with C57 mice
(Figure 1A). After 4 weeks, 4 of 23 C57 mice (17%) versus
8 of 20 Gal-3 KO mice (40%) died. On necropsy, dead
animals from Gal-3 KO mice had larger hearts (Figure 1B).
However, the cause of death was independent of cardiac
rupture because 38% of C57 and 32% of Gal-3 KO mice
presented with signs of cardiac rupture at necropsy. Infarct
size at 24 hours after MI was similar between the groups
(Figure 1C).
Echocardiographic examination revealed LV dilation and
a significant decrease in contractility at 1 week after MI
(Figure 1D). Interestingly, those parameters were even more
severely affected in Gal-3 KO mice with MI (Figure 1D),
showing that deficiency of Gal-3 unfavorably modified VR
and function. LV dilation was still higher in Gal-3 KO mice
at 4 weeks (Figure 1D). Long-term LV function was
significantly reduced in both genotypes with MI
(Figure 1D). At 4 weeks, although systolic function in MI
groups was similar, the dysfunction in Gal-3 KO mice after
MI started earlier in the evolution of MI (Figure 1, D and E).
Necropsy
By the end of the first week, cardiac mass index and the
lung weight/body weight ratio (pulmonary congestion)The American Journal of Pathology - ajp.amjpathol.orgsignificantly increased in Gal-3 KO mice with MI compared
with the sham and MI controls, suggesting a deficiency of
Gal-3 in animals with MI exacerbated cardiac remodeling
and failure (Table 1). To determine whether lack of Gal-3
affected the size of the infarction, the injury zone was also
measured at 1 day after MI. The infarct size at 24 hours was
33%  2.2% in C57 mice and 33%  0.5% in Gal-3 KO
mice. During the chronic phase, ventricular hypertrophy
after MI was significantly higher in both groups, whereas
pulmonary congestion remained compensated (Table 1).
Macrophage Infiltration and Expression of Markers of
Alternative Activation at 7 Days after MI
Deletion of Gal-3 markedly prevented macrophage infiltra-
tion at the infarct zone (Figure 2A) and significantly
increased the expression of mannose receptor (CD206) and
YM1 (both markers of M2 macrophages), suggesting that
Gal-3 is not only essential for inducing early macrophage
infiltration but also for a proinflammatory M1 profile
(Figure 2, B and C).
Cytokine Expression
The infarct zone of C57 mice exhibited considerable high
amounts of mRNA for TNF-a, whereas in Gal-3 KO mice it
was completely prevented (Figure 3A). In contrast, the real-
time quantitative RT-PCR analysis found that the expres-
sion of IL-10 and IL-6 was higher in the infarct zone of
Gal-3 KO mice than in C57 mice (Figure 3, B and C).
Collagen Concentration, MMP-2 Activity, and TGF-b
Expression
Lack of Gal-3 in mice with MI markedly prevented the
increase in collagen at the infarct zone throughout the MI
evolution (Figure 4A). In addition, at 1 week after MI, the
gelatinolytic activity of MMP-2 was highly enhanced in
Gal-3 KO mice (Figure 4B). Moreover, lack of Gal-3 pre-
vented the expression of TGF-b (Figure 4C). Thus, these1793
Figure 2 A: Quantification of F4/80þ macrophages. Inset: Overlay
histogram showing C57 myocardial infarction (MI) samples in gray and
galactin-3 (Gal-3) knockout (KO) (Lgals3-/-) MI samples in black. The blue
marker of the inset shows specific staining of the indicated antibody. B
and C: Expression of M2 phenotype markers CD206þ (also known as Mrc1)
and YM1 (also known as Chil1) in the infarct zone at 1 week. n Z 5 C57 MI
(A); nZ 6 Gal-3 KO MI (A); n Z 3 C57 MI (B and C); nZ 8 Gal-3 KO MI (B
and C). *P < 0.05 versus C57. A.U., arbitrary units.
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Figure 3 Quantification of cytokine expression by quantitative real-
time RT-PCR (RT-qPCR) in the infarct zone at 7 days. A: The lack of
galactin-3 (Gal-3) significantly prevents the expression of tumor necrosis
factor Tnf (also known as TNF-a). B and C: At the same time, the lack of Gal-
3 further enhances the expression of Il10 (also known as IL-10) (B) and Il6
(also known as IL-6) (C). n Z 3 C57 MI (AeC); n Z 8 Gal-3 KO MI (AeC)
*P < 0.05 versus C57. A.U., arbitrary units; Gal-3, galactin-3, also known as
Lgals3; KO, knockout; MI, myocardial infarction.
Cassaglia et alresults indicate that Gal-3 regulates not only the synthesis of
collagen but also the activity of MMP-2.
At an early stage, myocardial fibrosis at the remote zone
was similar among groups (Figure 5A), whereas the pro-
gressive increase in fibrosis observed in C57 MI mice at 4
weeks was prevented in Gal-3 KO mice (Figure 5B).1794Histologic and Morphometric Analysis
Scar thickness and scar thickness ratio were quantified at 1
and 4 weeks (Figure 6, A and B). At 1 week after MI, the
scar thickness was significantly reduced in Gal-3 KO miceajp.amjpathol.org - The American Journal of Pathology
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(n = 6) (n = 6) (n = 8) (n = 10)
Figure 4 A: Genetic deletion of galactin-3
(Gal-3, also known as Lgals3), extensively pre-
vents the collagen deposition in the myocardial
infarct (MI) region at 1 and 4 weeks. B: Repre-
sentative image of zymographs and quantification
of matrix metalloproteinase (MMP)-2 activity in the
infarct region at 1 week after myocardial infarction
(MI). C: Genetic deletion of Gal-3 significantly at-
tenuates the expression of transforming growth
factor (Tgfb1, also known as TGF-b). Number of
animals is shown between parentheses. *P < 0.05
versus C57 mice. Original magnification,400 (A).
Scale bars Z 40 mm (A). A.U., arbitrary units; KO,
knockout.
Galectin-3 on Healing and Remodelingcompared with C57. Although at 4 weeks, no differences
were found between the groups, in C57 mice the scar
thickness was progressively decreasing from 1 to 4 weeks,
whereas in Gal-3 KO mice the scar thickness was thinnestA
B C57 Sham Gal-3 KO Sham 
Gal-3 KO MIC57 MI
C57 Sham Gal-3 KO Sham
Gal-3 KO MIC57 MI
The American Journal of Pathology - ajp.amjpathol.orgfrom the early stage of MI (Figure 6, A and B). At 1 and 4
weeks, the infarct size was significantly larger in Gal-3 KO
animals but similar at 4 weeks (Figure 6C). With all results
considered together, the discrepancy observed betweenFigure 5 Myocardial collagen volume fraction
quantification at remote zone at 1 week (A) and 4
weeks (B) after myocardial infarction (MI) or sham
operation. No differences are observed after 1
week between the sham and MI groups. MI
significantly increases the fibrosis at remote zone
after 4 weeks, which is extensively prevented in
galactin-3 (Gal-3) knockout (KO) (Lgals3-/-) mice.
The number of mice analyzed per group are in
parentheses on the image. *P < 0.05 versus Gal-3
KO MI. Scale bars Z 40 mm (A and B).
1795
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D 4 weeks after MI
Figure 6 A: At 1 week, galactin-3 (Gal-3) knockout (KO) mice, also known as Lgals3-/- mice, with myocardial infarction (MI) have the thinnest infarct zone,
larger expansion, and larger ventricular cavity size. B: At 4 weeks after MI, scar and septum thicknesses are similar between the groups. C: Representative images of
Masson trichrome stained sections and infarct size at 1 and 4 weeks. D: Representative images of rodhamine staining section and quantification of myocyte cross-
sectional area (MCSA) in the remote zone at 4 weeks. MI progresively increases MCSA from the early stages; at 4 weeks, MCSA is slightly but significantly attenuated
in infarcted Gal-3 KO mice. *P < 0.05 versus C57 MI mice; yP < 0.05 versus mice in the sham group. Original magnification: 20 (C); 400 (D). Scale barsZ 40
mm (D).
Cassaglia et alinfarct size at 24 hours, 7 days, and 4 weeks suggests that
larger MI observed at 7 days in Gal-3 KO mice may be
related to larger expansion but not necessarily to major
infarct size. Myocyte cross-sectional area at 4 weeks was
significantly increased in both strains with MI. However, the
progressive increase in hypertrophy observed in C57 mice
with MI was clearly prevented in mice that lacked Gal-3
(Figure 6D).Discussion
The temporal evolution of wound healing after MI begins
with a robust inflammatory response followed by a progres-
sive suppression of inflammation and the formation of a
fibrous scar. Gal-3 plays an essential role in cardiovascular
pathophysiologic processes by regulating acute and chronic1796inflammatory responses.16,18,27e30 However, the role of that
lectin in the temporal evolution of wound healing, VR, and
function after MI is still far from being elucidated. We found
that Gal-3 regulates macrophage infiltration from the onset of
MI as well as the expression of macrophage markers for
alternative activation and the expression of proinflammatory
and anti-inflammatory cytokines. Interestingly, the lack of
Gal-3 significantly reduced the survival. In addition, these
findings corroborate that Gal-3 is a key mediator for the
formation and remodeling of the fibrous scar because the lack
of Gal-3 attenuated the expression of TGF-b and increased
the activity of MMP-2 in the infarct zone, prevented the
collagen deposition along the evolution of MI, and increased
the scar thickness ratio and expansion index. Finally, lack of
Gal-3 severely exacerbated the evolution of global remodel-
ing and dysfunction from the beginning of MI. Thus, these
findings strongly suggest that Gal-3 is a determinant factor forajp.amjpathol.org - The American Journal of Pathology
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results also indicate that the leading role of Gal-3 is not only
limited to the infarct zone wound healing but also has a direct
influence on cardiac structural changes and function along the
temporal evolution of MI.
A few hours after the loss of cardiac myocytes, necrotic
cells are removed by an intense and coordinated immune
response that completes the replacement of the injured area
with scar tissue. The development of this immune response
has direct implications in the evolution of VR. After MI, a
complex pool of signals from myocardial injury induces
macrophage infiltration and differentiation. Gal-3 increases
early in the injured zone and reaches the maximum
expression from 7 to 14 days afrer MI.17,19 Previous studies
suggested that Gal-3 is required for macrophage infiltration
and function, cytokine expression, and collagen synthesis in
cardiovascular pathology.16,27e29 However, the role of Gal-
3 in the temporal evolution of wound healing and its
involvement in the evolution of RV are unknown. We
analyzed the role of Gal-3 in the evolution of macrophage
infiltration and its influence on VR and function at 1 and 4
weeks after MI. At 1 week after MI, we found that Gal-3
deficiency reduces the infiltration of macrophages and the
expression of TNF-a and increases the expression of M2
macrophage markers, IL-6, and IL-10. Recently, Shirakawa
et al31 reported that Gal-3 is markedly increased in macro-
phages isolated from MI and contributes to their phenotypic
polarization and repairing, at least in part by secreting
proinflammatory and anti-inflammatory cytokines. In hy-
pertension, Gal-3 KO mice enhanced the expression of IL-
10,16 and this cytokine promoted the infiltration of M2
macrophages in the MI area.31 Thus, these results, in line
with previous reports,16,31 add new information and indicate
that Gal-3 is a critical player in the regulation of temporal
evolution of healing, scar formation, and global remodeling
and function. These data strongly suggest that Gal-3 is
required for the temporal evolution of phenotypic and
functional polarization of M1/M2 macrophages and proin-
flammatory and anti-inflammatory cytokine expression in
wound healing. Surprisingly, under the experimental con-
ditions of this study, Gal-3 KO mice with infarction had a
greater increase in IL-6; however, why the deficit of Gal-3
increased IL-6 is not completely clear. It is generally
accepted that IL-6 has proinflammatory and profibrotic
functions,32 and this study found that the lack of Gal-3 leads
to a reduction in IL-6.16 Nevertheless, ambivalent effects of
IL-6 have been described to rely on the activation of two
major signaling cascades.33 Accordingly, under certain
experimental conditions, the deficit of Gal-3 was linked to
an increase in IL-6.34,35 Because IL-10 and IL-6 have
recently been reported to promote the polarization of M2
macrophages through STAT3,31 the current study results
strongly suggest that after MI both cytokines may contribute
to the mechanism by which Gal-3 regulates the enhanced
expression of markers clearly indicative of macrophage
polarization toward the M2 subtype.The American Journal of Pathology - ajp.amjpathol.orgThe reduction in collagen synthesis by Gal-3 deficiency
has been widely established.16,27,28,36 After MI, the synthesis
of collagen in the infarct zone starts within the first 7 days and
progressively reaches a plateau between 4 and 6 weeks
later.37 The dynamics of collagen synthesis is an important
determinant of the mechanical properties and remodeling of
the infarcted wall and contributes to the evolution of the
global VR. Thus, the decrease in fibrosis reduces the tensile
strength of the infarcted wall, favoring the expansion and
adverse remodeling.22 These findings confirm that the deficit
of Gal-3 prevents collagen synthesis in the MI area and the
remote zone throughout the evolution of MI.
TGF-b is upregulated after MI, and its signaling pathways
actively participate in post-MI healing and remodeling.38
After MI, macrophages and lymphocytes that infiltrate into
the infarct zone are known to release myocardial TGF-b for
promoting fibroblast activation and collagen synthesis.39
Studies performed in culture fibroblasts found that TGF-b
leads to extracellular protein synthesis and concomitant
suppression of MMP.40 In the present study, the increase in
TGF-b observed in the infarct zone of control animals was
markedly attenuated in Gal-3 KO mice, suggesting a
reduction in collagen synthesis. TGF-b is a key molecular
link between the inflammatory and reparative response.
However, the cellular response to TGF-b at early stages
after MI may be attenuated by the abundance of other
proinflammatory mediators. When debris from necrotic tis-
sue is cleared, TGF-b in association with other neurohor-
monal mediators and Gal-3 regulate fibroblast proliferation
and fibrogenic response. Nevertheless, although the reduc-
tion in fibrosis observed in Gal-3 KO mice may be
explained by a reduction in TGF-b, these results also indi-
cate that it is not the only mechanism because the lower
collagen amount observed in the MI zone of KO mice could
also be the result of an increase in the collagenolytic activity
of MMP-2. The enhancement of MMP-2 activity seems to
be important in wound healing and remodeling of the infarct
zone because the MMP-2 deletion or pharmacologic inhi-
bition reduces both cardiac rupture and remodeling after MI
in mice.41 Previous findings identified that Gal-3 is a sub-
strate that gelatinizes MMP-2 and that its degradation may
play a role in modulating the biological activities of Gal-3,42
which may explain the enhancement in the activity of
MMP-2 found in Gal-3 KO mice with MI. Thus, these re-
sults indicate that in the evolution of the reparative process,
Gal-3 plays a critical role not only in the synthesis but also
in the collagen turnover in the MI area.
Ben-Mordechai et al43 reported that a depletion of
macrophages markedly increases post-MI mortality in
mice and that mesenchymal stem cells could influence
post-MI healing in part by modulating the macrophage
phenotype. Therefore, the anti-inflammatory and anti-
fibrotic effects observed by depletion of Gal-3 from the
beginning of MI strongly suggest that the greater expan-
sion, adverse remodeling, and lower survival observed in
those mice could have occurred because of the factors1797
Cassaglia et almentioned above. In these experiments, the survival rate
in Gal-3 KO mice with MI was significantly reduced. The
cause of death was independent of cardiac rupture but
closely related to the effect of the lack of Gal-3 on healing
and remodeling. Necropsy of the dead animals found
cardiac rupture in 38% of the C57 mice and 32% of the
Gal-3 KO mice. Although other causes of mortality were
not studied here, the adverse early remodeling and pul-
monary congestion observed in Gal-3 KO mice with MI
strongly suggest that uncompensated heart failure may be
the main cause of death. Furthermore, the possibility of
arrhythmias should also be considered.
The dynamics of the infarct zone healing are closely related
to the natural evolution of VR. This remodeling is character-
ized by the progressive thinning of the MI area followed by
hypertrophy and fibrosis of the noninfarcted myocardium,
ventricular dilation, and failure. The benefits or the counter-
productive effects of inhibiting the reparative process in the
evolution of the RV is a matter of controversy.6 Studies in
animals reported that the inhibition of the reparative process
can reduce the infarct size and improve the evolution of the
VR.44,45 However, the early use of anti-inflammatory drugs
after infarction promoted the thinning and expansion of the
infarct zone in animals and increased the incidence of cardiac
rupture in patients.46 Thus, a defect in the healing process or an
increase in the infarct size and parietal stress were the main
determinants of the expansion and the appearance of adverse
clinical events, heart failure, and death.22 In line with the
affected natural evolution of the reparative process, we found
that Gal-3 KO mice with MI exhibited a reduction in the scar
thickness ratio, enhanced infarct expansion, and ventricular
dilation and dysfunction. The expansion of the MI zone refers
to the radial thinning and circumferential increase in the extent
of the infarct area that occurs during the days to weeks after an
acute MI. Previous reports found different pathologic mecha-
nisms that explain the link between the inflammatory process
during healing and its relationship with the global VR and
dysfunction.16,22,47 In this regard, it was previously found that
the reduction in the inflammatory cellular infiltrate delays the
reparative response after MI and increases scar thinning and
expansion, dilation, and systolic dysfunction.22 These findings
indicate that at 7 days, Gal-3 KO mice had the significantly
thinnest scar and larger expansion when compared with con-
trols. These results aid our understanding, at least in part, of the
discrepancy observed between the infarct size at 7 days when
compared with 1 day and 4 weeks. The method used for
measuring the scar size is based on the quantification of the
internal and external length of the infarcted segment in relation
to the total perimeter of the ventricular cavity. Because early
stages of post-MI remodeling are mainly limited to infarct
region and accompanied by a thinner and larger expansion, this
finding may explain the reason why Gal-3 KO mice had larger
infarct sizes than C57 mice at 1 week after MI but similar
infarct sizes at 1 day and 4 weeks. Furthermore, a natural
positive selection of the healthiest animals may explain the
discrepancy that we observed in the evolution of the1798remodeling and mortality that allowedmice withMI to survive
for 4 weeks.
Despite the potential role of Gal-3 as a prognostic
biomarker in heart failure,18 at 4 weeks after MI, differences
in cardiac hypertrophy (heart weight/body weight and heart
weight/tibia length) or cardiac function (LV ejection fraction
and fractional shortening) were not found, whereas differ-
ences were still found in the collagen content and myocyte
cross-sectional area between both genotypes. A recent study
found that Gal-3 is produced from macrophages and myofi-
broblasts at the early phase after pressure overload and from
cardiomyocytes at the late phase.48 This investigation did not
study whether Gal-3 is increased in cardiomyocyte at chronic
remodeling. However, on the basis of those results, although
the lack of differences may still be attributable to the natural
selection of the healthiest animals that survived to 4 weeks,
the role of Gal-3 on late phase of remodeling seems to be less
relevant when compared with the early phase. Nevertheless,
the loss of significance in cardiac function and remodeling at
4 weeks should be interpreted with caution because the
temporal evolution from 1 to 4 weeks reveals that genetic
mutation of Gal-3 KO mice accelerated the adverse remod-
eling. Therefore, our findings strongly suggest that Gal-3 is a
key player required for the temporal evolution of alternative
macrophages, cytokine expression, collagen turnover, and
scar formation during the wound healing process, which
plays a crucial role in structural remodeling, and function.
In summary, Gal-3 is an essential regulatory factor of post-
MI healing because it regulates the dynamics of the reparative
process, the phenotypic profile of macrophages, the proin-
flammatory and anti-inflammatory cytokine expression, and
fibrosis with the temporal evolution of the healing process in
mice. The deficit of Gal-3 diminished macrophage infiltration,
thus altering its phenotypic polarization and consequently the
dynamics of the reparative process, increasing the expansion
and aggravating the functional and histomorphometric evolu-
tion of cardiac remodeling. Our results strengthen the theory
that Gal-3 is essential for early wound healing. The fact that the
lack of Gal-3 prevented the 4-week fibrosis at the remote zone
suggests that blocking Gal-3 after healing while allowing its
physiologic response in the early phase may have a beneficial
effect on chronic remodeling. Additional studies on clarifying
the role of blockingGal-3 on long-term remodeling are needed.Study Limitations
The role of TGF-b has been widely studied in experimental
models of MI and remodeling.39,49 Our results indicate that
the lack of Gal-3 prevents the increase of TGF-b expression.
However, because we used an in vivo model of MI, these
results are limited to understanding the attenuated expres-
sion of TGF-b by Gal-3 KO at the infarct zone. Additional
studies examining the molecular basis involved in Gal-
3edependent TGF-b expression are required. A deep un-
derstanding of the role of Gal-3 in the regulation of thisajp.amjpathol.org - The American Journal of Pathology
Galectin-3 on Healing and Remodelingmultifunctional growth factor in healing and remodeling
requires performing studies in vitro, which the current study
protocol was not originally designed to do. Thus, further
investigation of the translational relevance of the present
study is needed.Acknowledgments
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